Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...
Sarah is an experienced writer and editor enthusiastic about helping readers live their healthiest and happiest lives. Before joining Forbes Health, Sarah worked as a writer for various digital ...
The weight loss drugs landscape in the UK underwent a seismic shift on 6 July 2026 when Wegovy – an injectable semaglutide – ...
NICE has recommended Wegovy ® (semaglutide injection) 2.4 mg as the first GLP-1 RA to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or ...
Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the type 2 diabetes and weight loss medication sold under the brand names Ozempic and Wegovy — can expire. If you’ve ...
As demand for injectable weight-loss medicines grows, experts are urging South Africans to check whether their medication is SAHPRA-registered, warning that unregistered products may carry serious ...
NEW ORLEANS, June 7, 2026 /PRNewswire/ -- New international study findings demonstrated positive results of the first injectable glucagon-like peptide-1 receptor agonist (GLP-1 RA) and amylin analogue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results